ALCOX (ALCOX) News
Follow ALCOX (ALCOX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Nicox unit milestone advances U.S. NDA funding into 2029
Nicox said a U.S. NDA approval milestone will fund operations into 2029, according to TradingView News. The company’s shares are tied to the event involving its NCX 470 program.
EQUITY | Sep 02, 2026, 06:37 AM UTC
L
Nicox extends cash runway into next-year reporting
Unaudited estimate by management says cash runway has been extended. Next reporting is the first half 2026 accounts in October 2026, with PDUFA dates described as FDA target completion timelines.
REGULATION | Sep 02, 2026, 05:37 AM UTC
L
Nicox sets April 2027 PDUFA date for NCX 470 glaucoma
Nicox announced an April 2027 Prescription Drug User Fee Act target date for NCX 470 in glaucoma.
EQUITY | Aug 27, 2026, 05:37 AM UTC